Tag: Dr Reddy’s Laboratories
CPHI & PMEC India Expo – 26 to 28 November 2024
The 17th edition of CPHI & PMEC India, organized by Informa Markets in India, returns in an advanced format, scheduled from 26 to 28...
Boehringer Ingelheim bans four Indian pharma firms
Multinational pharmaceutical giant Boehringer Ingelheim has acquired ad-interim injunctions against four Indian pharmaceutical companies. These companies had dispatched generic versions of a patent-protected drug...
Impact of new brands on Indian Pharma Industry
With the booming pharma industry in India, the new and coming brands give a promising outlook of the bright future of the pharma sector...
Binnopharm to acquire two anti-bacterial brands from Dr. Reddy’s
The Sistema Group company, Binnopharm Group, one of Russia’s leading pharmaceutical production companies via its affiliate joint-stock company’ Alium’, and Dr. Reddy’s Laboratories, an...
Dr Reddy’s launches generic version of Vimovo
Dr Reddy’s Laboratories announced the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo (Naproxen and Esomeprazole...
Dr Reddy’s to acquire select business divisions of Wockhardt in India
Dr Reddy’s Laboratories has announced that it has entered into a definitive agreement with Wockhardt to acquire selected divisions of its branded generics business...